Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Multiple Myeloma × Functional Status × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pelvic Muscle Strength and Function 1 Osteonecrosis 1 Neoplasms 1 Multiple Myeloma 1 Cognition Disorders 1 Chemotherapy-Related Cognitive Impairment 1 Breast Neoplasms 1

Interventions

Dexamethasone 418 Lenalidomide 264 Cyclophosphamide 246 Bortezomib 239 Melphalan 190 Calcium Dobesilate 165 fludarabine phosphate 112 daratumumab 103 Peripheral Blood Stem Cell Transplantation 99 carfilzomib 92 Thalidomide 90 Filgrastim 88 Mycophenolic Acid 82 fludarabine 81 pomalidomide 80 Whole-Body Irradiation 80 Busulfan 74 Tacrolimus 71 Granulocyte Colony-Stimulating Factor 66 Cyclosporine 58 dexamethasone acetate 56 ixazomib 55 Antilymphocyte Serum 50 dexamethasone 21-phosphate 49 auricularum 44 Etoposide 39 isatuximab 36 Radiotherapy 36 Stem Cell Transplantation 34 Methotrexate 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05276622 2024-12-12

PaCE-MM

UNC Lineberger Comprehensive Cancer Center

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡